Press Releases 2017

The Boston Scientific LOTUS™ Valve System demonstrated superior efficacy to CoreValve® in global REPRISE III trial at one year - May 16, 2017

Boston Scientific (NYSE: BSX) today announced positive results from the REPRISE III clinical trial, presented at the annual EuroPCR Scientific Program, in Paris.  Data from the study demonstrated that... 

Read more

Boston Scientific Closes Symetis Acquisition - May 16, 2017
Acquisition Expands Company’s Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease.

Read more

Top